Flordis/SFI receive another Australian government grant.

Tuesday, 16 November 2010 16:11

Following our successful achievement of receiving 2 of the largest herbal medicine clinical research grants in Australian history (Iberogast for dyspepsia, Ginsana for Chronic Obstructive Pulmonary Disease) we have just received another grant to improve the testing in our KeenMind neuroprotection study. This study will examine the effects of KeenMind on 310 healthy elderly subjects over 1 year, to compare their memory to subjects receiving placebo. This new grant will enhance the testing used to assess the effects of KeenMind, and amounts to a total of $174,000 over the next 2 years. KeenMind has been shown to improve brain and cognitive function, however, we do not fully understand how it works in the brain. Using novel brain imaging scans, the project will investigate whether 12-month administration of KeenMind improves brain markers of ageing and cognitive decline in the elderly population.

Nigel Pollard – Chief Executive Officer
+61 2 9431 7299